Sanofi
Emre Canaki and Stefanie Kutschmann pass a metal disk between them by way of gloveboxes inside a large steel machine.

Emre Canaki, Supervisor Deputy and Stefanie Kutschmann, Good Manufacturing Practice Officer, Frankfurt, Germany

Emre Canaki, Supervisor Deputy and Stefanie Kutschmann, Good Manufacturing Practice Officer, Frankfurt, Germany

Fourth Quarter & Full Year 2025 Results

Fourth quarter and full year 2025 results were reviewed by management during a live audio webcast with the financial community.

Learn more

Our Latest Articles

3D molecular model of a NANOBODY® molecule showing purple and gray spheres connected by bonds against a gradient background

Our Science

January 26, 2026

Two’s Company. Three’s a Crowd. Five Nanobody® Subunits? That Could Be a New Medicine.

Two women in black wetsuits standing on a beach with a surfboard, ready for surfing

The Power of Chasing A Dream

Every day, we chase the miracles of science to improve people’s lives. We apply our deep understanding of the immune system to develop breakthrough innovations in medicines and vaccines so you can focus on what matters most, chasing your dreams. If you’re chasing your dreams, remember... you’re not alone. We’re right beside you. 

 

People Stories

We’re proud to spotlight those who inspire us to keep going further in the work we do.

A woman wearing a black wetsuit holds a surfboard under blue skies and sunshine while looking out to the horizon with a hopeful and determined expression.​

Céline, living with secondary progressive multiple sclerosis

France

We are an R&D driven, AI-powered biopharmaceutical company committed to improving people’s lives and delivering compelling growth

About Us

Who We Are

We are an R&D driven,
AI-powered biopharma company committed to improving people’s lives and creating compelling growth.

Our Pipeline

5

Therapeutic areas

80

Compounds in clinical development

28

Clinical trials in phase 3

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Our Latest Press Releases


January 30, 2026
Press Release: Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease

January 29, 2026
Press release: 2025: strong sales and EPS growth. Continued profitable growth expected in 2026

January 23, 2026
Press Release: Sanofi's amlitelimab confirms its potential in atopic dermatitis

January 15, 2026
Press Release: Myqorzo and Redemplo approved in China